Transarterial chemoembolisation vs no intervention
Death during study period · people with liver metastases
It is very uncertain whether transarterial chemoembolisation changes mortality at 44 months from trial entry Number of participants compared with no intervention (very low certainty).
1 finding from 1 review
- Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases 2020 · Cochrane Headline outcomes onlyRR 0.83 [0.65, 1.07]1 study · 39 participantsVery low